Veera M. Rajagopal's profile photo

Veera M. Rajagopal

Featured in: Favicon nature.com Favicon substack.com

Articles

  • Dec 9, 2024 | nature.com | Georgios Voloudakis |Karen Therrien |Simone Tomasi |Veera M. Rajagopal |Ditte Demontis |John F. Fullard | +3 more

    AbstractPolygenic scores (PGS) enable the exploration of pleiotropic effects and genomic dissection of complex traits. Here, in 421,889 individuals with European ancestry from the Million Veteran Program and UK Biobank, we examine how PGS of 17 neuropsychiatric traits are related to membership in 22 broad professional categories.

  • Jul 28, 2024 | gwasstories.com | Veera M. Rajagopal

    Regular readers of my Substack would recognize my special interest in noncoding genome. Today, we explore a fascinating tale of how a mobile genetic element has been coloring the evolutionary journey of our human ancestors for hundreds of thousands of years. One of the biggest mysteries that scientists were wrestling with during the early days was the puzzling disconnect between size of the organisms and their genomes.

  • Jul 13, 2024 | gwasstories.com | Veera M. Rajagopal

    Until I was in academia, I worked within a small group of researchers who all pretty much had the same expertise as I had and so, I was never used to explaining certain genetic concepts during the scientific discussions. This worsened my—what advocates of good writing like Steven Pinker describe as—"curse of knowledge". I only realized this after I started working in industry. In my day job, I communicate genetic results to scientists whose expertise differ drastically from mine.

  • May 6, 2024 | gwasstories.com | Veera M. Rajagopal

    I hope your week is off to a great start! The past few days, I’ve been digging into the Spinocerebellar ataxia type 4 (SCA4) literature, inspired by a new NatureGenetics paper on the successful mapping of the causative gene and mutation underlying SCA4. I've read this work last year when it was preprinted and tweeted about it. I've mentioned this preprint in a couple of my past substack posts in relation to long-read sequencing, and discussed it in the Genetics podcast with Patrick Short.

  • Mar 29, 2024 | gwasstories.com | Veera M. Rajagopal

    Happy Friday! I’ve been thinking about the role of rare diseases in drug development this week. Drug companies are racing to sequence healthy volunteers in millions. But very few care about rare disease patients. As much as a healthy human carrying a beneficial mutation helps with drug development, a rare disease patient carrying a pathogenic mutation equally provide useful information. Rare disease informing drug development is one of my favorite topics.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →